Citigroup’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,632
Closed -$15K 8017
2018
Q2
$15K Buy
1,632
+386
+31% +$3.7K ﹤0.01% 7063
2018
Q1
$13K Buy
+1,246
New +$12.7K ﹤0.01% 6959
2017
Q3
Sell
-61,175
Closed -$580K 7604
2017
Q2
$580K Sell
61,175
-402,137
-87% -$3.21M ﹤0.01% 3855
2017
Q1
$3.09M Sell
463,312
-232,159
-33% -$1.38M ﹤0.01% 2069
2016
Q4
$4.26M Sell
695,471
-465,497
-40% -$2.32M ﹤0.01% 2018
2016
Q3
$5.93M Sell
1,160,968
-231,109
-17% -$1.23M 0.01% 1514
2016
Q2
$8M Sell
1,392,077
-125,046
-8% -$761K 0.01% 1191
2016
Q1
$9.21M Sell
1,517,123
-187,994
-11% -$1.12M 0.01% 1070
2015
Q4
$10.9M Buy
1,705,117
+36
+0% +$227 0.01% 1094
2015
Q3
$10.3M Buy
1,705,081
+1,312,376
+334% +$8.16M 0.01% 1123
2015
Q2
$2.42M Buy
392,705
+392,620
+461,906% +$2.41M ﹤0.01% 2346
2015
Q1
$0 Buy
+85
New +$418 ﹤0.01% 7602

Other funds holding CO

Citigroup's CO Position: Q3 2018 in Review

Citigroup sold out of Global Cord Blood Corporation (CO) in Q3 2018, closing a stake of 1,632 shares — an estimated $15K sold.

Citigroup first reported a position in CO in Q1 2015 and held it in 12 quarters. The position peaked at $10.9M in Q4 2015. 43 funds tracked by Wall St. Rank hold CO as of Q3 2018.

  • Citigroup reported no remaining Global Cord Blood Corporation position as of Q3 2018 after selling out during the quarter.
  • Citigroup sold 1,632 Global Cord Blood Corporation shares in Q3 2018, an estimated $15K.
  • Citigroup first reported a position in Global Cord Blood Corporation in Q1 2015 and held it in 12 quarters.
  • Citigroup's Global Cord Blood Corporation position peaked at $10.9M in Q4 2015.
  • 43 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2018.

Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.